The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2023

Filed:

Feb. 28, 2020
Applicant:

Rani Therapeutics, Llc, San Jose, CA (US);

Inventor:

Mir Imran, Los Altos Hills, CA (US);

Assignee:

Rani Therapeutics, LLC, San Jose, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 31/00 (2006.01); A61M 5/142 (2006.01); A61M 25/10 (2013.01); A61M 25/01 (2006.01);
U.S. Cl.
CPC ...
A61M 31/002 (2013.01); A61M 5/14276 (2013.01); A61M 25/0116 (2013.01); A61M 25/10 (2013.01); A61M 31/00 (2013.01); A61M 31/007 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3344 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/8231 (2013.01); A61M 2210/1042 (2013.01); A61M 2210/1053 (2013.01); A61M 2230/208 (2013.01); A61M 2230/60 (2013.01);
Abstract

Embodiments of the invention provide swallowable devices, preparations, and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs or other therapeutic agents (TA) into a wall of the GI tract such as the stomach or small intestine. The swallowable device comprises a sensor, a combustible propellant (CP) and a therapeutic agent preparation (TAP) comprising at least one TA. The sensor triggers the CP to ignite and propel the TAP into the wall of the GI tract in response to an external condition or change in external condition. Embodiments of the invention are particularly useful for orally delivering drugs or other TAs which are degraded within the GI tract and require parenteral injection.


Find Patent Forward Citations

Loading…